kainic acid has been researched along with Basal Ganglia Diseases in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 4 (66.67) | 18.7374 |
| 1990's | 1 (16.67) | 18.2507 |
| 2000's | 1 (16.67) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Habaguchi, T; Ohtinata-Sugimoto, J; Saitoh, K; Sakamoto, T; Takakusaki, K | 1 |
| Hunter, JF; Rieke, GK; Scarfe, AD | 1 |
| Divac, I | 1 |
| Itoga, E; Kishida, T; Kito, S; Nanba, K; Shimoyama, M | 1 |
| Altar, CA; Christakos, S; German, D; Iacopino, A; Sonsalla, PK | 1 |
| Allen, GS; Huang, S; Tulipan, N; Whetsell, WO | 1 |
6 other study(ies) available for kainic acid and Basal Ganglia Diseases
| Article | Year |
|---|---|
Basal ganglia efferents to the brainstem centers controlling postural muscle tone and locomotion: a new concept for understanding motor disorders in basal ganglia dysfunction.
Topics: Animals; Atropine; Basal Ganglia; Basal Ganglia Diseases; Bicuculline; Brain Stem; Cats; Choline O-Acetyltransferase; Disease Models, Animal; Efferent Pathways; Electric Stimulation; Electromyography; Evoked Potentials, Motor; Excitatory Amino Acid Agonists; GABA Agonists; GABA Antagonists; gamma-Aminobutyric Acid; Kainic Acid; Locomotion; Muscarinic Antagonists; Muscimol; Muscle Tonus; N-Methylaspartate; Neural Inhibition; Picrotoxin; Stimulation, Chemical | 2003 |
L-pyroglutamate: an alternate neurotoxin for a rodent model of Huntington's disease.
Topics: Animals; Basal Ganglia; Basal Ganglia Diseases; Corpus Striatum; Disease Models, Animal; Huntington Disease; Kainic Acid; Male; Mice; Microscopy, Electron; Pyrrolidinones; Pyrrolidonecarboxylic Acid | 1984 |
The neostriatum viewed orthogonally.
Topics: Animals; Basal Ganglia Diseases; Behavior, Animal; Cats; Cerebral Cortex; Corpus Striatum; Kainic Acid; Neural Pathways; Rats; Species Specificity | 1984 |
Binding experiments of muscarinic acetylcholine and dopamine receptors in human brains with emphasis on a case of striatonigral degeneration.
Topics: Animals; Basal Ganglia Diseases; Brain; Caudate Nucleus; Corpus Striatum; Humans; Hydroxydopamines; In Vitro Techniques; Kainic Acid; Oxidopamine; Rats; Rats, Inbred Strains; Receptors, Cholinergic; Receptors, Dopamine; Receptors, Muscarinic; Substantia Nigra | 1982 |
Calbindin-D28K-containing neurons in animal models of neurodegeneration: possible protection from excitotoxicity.
Topics: Animals; Basal Ganglia Diseases; Biogenic Amines; Calbindin 1; Calbindins; Calcium; Cell Survival; Disease Models, Animal; Kainic Acid; Mice; Mice, Inbred C57BL; MPTP Poisoning; Nerve Degeneration; Nerve Tissue Proteins; Neurons; Neurotoxins; Quinolinic Acid; Quinolinic Acids; Rats; Rats, Inbred Strains; RNA, Messenger; S100 Calcium Binding Protein G | 1992 |
Neonatal striatal grafts prevent lethal syndrome produced by bilateral intrastriatal injection of kainic acid.
Topics: Animals; Animals, Newborn; Basal Ganglia Diseases; Corpus Striatum; Disease Models, Animal; Female; Huntington Disease; Kainic Acid; Rats; Rats, Inbred Lew | 1986 |